Form 4: TransMedics Group CFO Stephen Gordon Executes Stock Option and Sells Shares
SEC Form 4 Filing
Stephen Gordon, CFO of TransMedics Group, exercised stock options and sold shares on June 3, 2024, according to a recent SEC filing.
Summary
- On June 3, 2024, Stephen Gordon, the Chief Financial Officer of TransMedics Group, Inc., exercised stock options to acquire 2,060 shares of common stock at a price of $38.46 per share.
- Simultaneously, Gordon sold 2,060 shares of common stock at a price of $135.93 per share.
- These transactions were executed under a pre-arranged Rule 10b5-1 trading plan established on September 14, 2023.
- Following these transactions, Gordon directly owns 21,299 shares of TransMedics Group, Inc.
Sentiment
Score: 5
Explanation: The sentiment is neutral as it is a standard disclosure of insider trading activity. The transactions are part of a pre-arranged trading plan, which mitigates concerns about opportunistic trading.
Industry Context
This filing is a routine disclosure of insider transactions and provides transparency to investors regarding the trading activities of company executives.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the increased supply of shares in the market.
- The filing provides transparency to stakeholders regarding insider trading activities.
Key Dates
| Date | Description |
|---|---|
| 09/14/2023 | Date of Rule 10b5-1 trading plan adoption |
| 02/24/2025 | Date the option is fully vested |
| 02/24/2031 | Expiration date of the stock option |
| 06/03/2024 | Date of stock option exercise and share sale |
| 06/05/2024 | Date of Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.